Last Updated 17 September 2021.
7 Vaccines Approved for Use in Brazil
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 99 countries
33 trials in 17 countries
Approval Source: reuters.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 71 countries
21 trials in 7 countries
Approval Source: reuters.com
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 64 countries
11 trials in 17 countries
Approval Source: reuters.com
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 121 countries
40 trials in 21 countries
Approval Source: reuters.com
-
Serum Institute of India
Covishield (Oxford/AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 45 countries
2 trials in 1 country
Approval Source: bio.fiocruz.br
-
Sinopharm (Beijing)
BBIBP-CorV (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 64 countries
14 trials in 8 countries
Approval Source: gov.br
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
19 trials in 7 countries
Approval Source: apnews.com
10 Vaccines in Clinical Trials in Brazil
-
Clover
SCB-2019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 11 countries
-
Medicago
Plant-based VLP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 5 countries
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 99 countries
33 trials in 17 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 64 countries
11 trials in 17 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 121 countries
40 trials in 21 countries
-
Oxford/AstraZeneca
AZD2816- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 2 countries
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries
-
Chinese Academy of Medical Sciences
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 3 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
19 trials in 7 countries
-
Mahidol University
NDV-HXP-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries